Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|July 27, 2000
Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomasE Späth-Schwalbe, I Genvresse, A Koschuth, et al.
The British Journal of Dermatology|December 21, 2000
Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbineI Genvresse, B Flath, K Akrivakis, et al.
Anticancer Research|July 26, 2007
The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancerD Pollmann, S Siepmann, R Geppert, et al.
Cancer Treatment Reports|February 1, 1987
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinomaH Wagner, K Possinger, K Bremer, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Detection of amplifiable messenger RNA in the serum of patients with lung cancerM Fleischhacker, T Beinert, M Ermitsch, et al.
European Journal of Haematology|May 31, 2001
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapyO Sezer, K Niemöller, O Kaufmann, et al.
Annals of Hematology|October 24, 2000
Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?I Genvresse, E Späth-Schwalbe, H Meisel, et al.
European Journal of Haematology|February 13, 2001
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myelomaO Sezer, C Jakob, J Eucker, et al.
Fortschritte Der Medizin|April 20, 1987
[Prognostic factors in adenocarcinoma of the kidney]K Possinger, H Wagner, R Beck, et al.
Anti-Cancer Drugs|April 22, 1999
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerK Possinger, M Kaufmann, R Coleman, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|July 27, 2000
Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomasE Späth-Schwalbe, I Genvresse, A Koschuth, et al.
The British Journal of Dermatology|December 21, 2000
Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbineI Genvresse, B Flath, K Akrivakis, et al.
Anticancer Research|July 26, 2007
The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancerD Pollmann, S Siepmann, R Geppert, et al.
Cancer Treatment Reports|February 1, 1987
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinomaH Wagner, K Possinger, K Bremer, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Detection of amplifiable messenger RNA in the serum of patients with lung cancerM Fleischhacker, T Beinert, M Ermitsch, et al.
European Journal of Haematology|May 31, 2001
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapyO Sezer, K Niemöller, O Kaufmann, et al.
Annals of Hematology|October 24, 2000
Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?I Genvresse, E Späth-Schwalbe, H Meisel, et al.
European Journal of Haematology|February 13, 2001
Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myelomaO Sezer, C Jakob, J Eucker, et al.
Fortschritte Der Medizin|April 20, 1987
[Prognostic factors in adenocarcinoma of the kidney]K Possinger, H Wagner, R Beck, et al.
Anti-Cancer Drugs|April 22, 1999
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerK Possinger, M Kaufmann, R Coleman, et al.
Pageof 17